AMPH

NASDAQStock

Amphastar Pharmaceuticals, Inc.

$18.00-0.76 (-4.05%)

52-Week Range

$18.18
$30.81

Key Stats

Market Cap

827.1M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Volume

649.3K

Avg Volume

781.8K

Performance

1M

-36.43%

3M

-30.92%

6M

-33.35%

YTD

-31.31%

1Y

-30.74%

3Y

-51.14%

5Y

-5.09%

Price Chart

ETF Exposure

AMPH is held by 115 ETFs

ETFFund NameWeight
AOKiShares Core 30/70 Conservative Allocation ETF0.00%
AOMiShares Core 40/60 Moderate Allocation ETF0.00%
AORiShares Core 60/40 Balanced Allocation ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
MMTMState Street SPDR S&P 1500 Momentum Tilt ETF0.00%
PreviousPage 3 of 3

About AMPH ETF Exposure

Amphastar Pharmaceuticals, Inc. (AMPH) is held by 115 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 827.1M, AMPH is a widely held institutional stock. The stock currently trades at $18.00. Investors can gain exposure to AMPH through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AMPH, sorted by portfolio weight.